LetterPub 0712 Pt2

by | Jul 1, 2012

Professor Ruggiero on HIV and AIDS

Marco Ruggiero is a professor at the Institute of Experimental Pathology and Oncology at the University of Florence. Professor Ruggiero belongs to a small club of scientists who do not believe that HIV is the cause of AIDS. Professor Peter Duesberg, PhD, at the University of California at Berkeley championed this theory in the early 1990s. Duesberg was rewarded for his public discussion of HIV not being the cause of AIDS with ostracism from his peers, a series of denials for grants for his research, and general labeling as an AIDS “dissident.” In the mid-1990s, dissidents were vigorously expounding on a non-HIV causation of AIDS. Medical societies, AIDS groups, and world health authorities condemned dissidents and recommendations for not using anti-HIV therapies. Professor Ruggiero has examined the controversy and argues that a non-HIV causation for AIDS not only is supported by hypothetical argument but also by experimental data and alternative therapies for AIDS. Ruggiero dismisses the “dissident” label. He cites a growing discussion is taking place at AIDS conferences that HIV by itself is not sufficient to explain AIDS causation.

Ruggiero agrees that HIV is associated with AIDS process; that antiretroviral agents do reduce HIV burden; and that markers for AIDS, including viral loads and white blood cell counts, are modified by HIV drug treatments. However, studies with immune supporting agents, including an agent called GcMAF, also reveal changes in HIV burden and modify white blood cell counts. Ruggiero cites data demonstrating improvement in the aforementioned when antiretroviral agents and other HIV drugs were unsuccessful. He argues that an immune-supporting agent for the AIDS process would make better sense for the treatment of AIDS and offers another option than depending on controlling HIV viral load. Ruggiero proposes a novel development utilizing what he calls a specially prepared probiotic yogurt to serve as primary immune support agent.

We are pleased to publish the full interview of Professor Ruggiero by Spanish journalist Jacques Fernández de Santos in this issue.

Dr. Heyman on Metabolic Syndrome in Men

Andrew Heyman, MD, is a faculty member at the University of Michigan, where he has worked with the Complementary and Alternative Medicine Research Center. Dr. Heyman continues his work in the CAM field and currently has a private practice in Virginia. His research focuses on metabolic syndrome in men and shows its relationship to adrenal-related stress and abnormalities in testosterone. Dr. Heyman has found that as men age, there is a tendency to have adrenal gland dysfunctioning with abnormal cortisol levels. He particularly likes studying adrenal physiology with the use of salivary cortisol multipoint studies. When cortisol levels are abnormal, especially in relationship to abnormal, usually low, testosterone levels, there is a high likelihood that there will be insulin dysfunctioning and metabolic syndrome. Heyman believes that adrenal gland dysfunctioning with abnormal cortisol levels does not necessarily mean that the primary problem is insufficient adrenal functioning requiring cortisol supplementation. Instead, he focuses on the brain, which may be the “cause” of why the adrenal gland misfunctions during stress. Heyman thinks that brain centers, including the pituitary, hypothalamus and connected systems, falter as stress builds. Subsequently, the brain fails to stimulate the adrenal gland, leading to adrenal dysfunction. Rather than supplement testosterone and hydrocortisone Heyman would recommend supporting the brain. He would advise the use of behavioral therapies such as meditation and breathing techniques to calm stress. Heyman supports the use of adaptogen herbals that tend to calm the brain and adrenal system. He also likes to use nutrients to rebuild the adrenal and support testosterone rather than immediately working with hormone replacement.

Dr. Andrew Heyman is interviewed by Nancy Faass.

Sarah Wood, ND, on Low Testosterone

Dr. Sarah Wood is a graduate of the National College of Naturopathic Medicine. She practices in Oregon and is a staff physician with Labrix Clinical Services. Dr. Wood examines low testosterone as a primary factor for men developing metabolic syndrome in middle age. Wood would argue that testosterone deficiency by itself would play a pivotal role in insulin dysfunctioning, disrupting lipid control, and setting in play the conditions associated with metabolic syndrome. Dr. Wood reviews the importance of examining testosterone hormone levels in men and recommends hormone replacement unless there is established cancer diagnosis or risk. She also advises herbal support therapies for low testosterone.

Advertisement

Jonathan Collin, MD

Author

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • Integrative Cancer Symposium 2026 – Believe BIG

    Sheraton, Towson MD Towson, MD, United States

    Optimize Your Health. Transform Your Future. Join us for this dynamic one-day experience designed for anyone seeking to take a proactive, whole-body approach to health. Integrative oncology is a dynamic and rapidly evolving field, unveiling groundbreaking discoveries and new possibilities every day. This year’s one-day conference will take place at the Sheraton in Towson, Maryland from 9am – 5pm and offers both in-person and virtual attendance options. This event brings together leading experts in integrative oncology, functional medicine, and wellness. Discover cutting-edge approaches to prevention, treatment, recovery, and whole-person wellness at the Integrative Cancer Symposium Believe Big 2026. Learn from leading clinicians, researchers, and innovators in integrative oncology as they explore emerging therapies, metabolic and lifestyle approaches, mistletoe therapy, nutrition, environmental health, mindset, and more. Whether you are navigating cancer personally, supporting a loved one, or simply looking to optimize your health and reduce future risk, this powerful one-day experience offers practical tools, fresh insights, and meaningful connection.

  • PLMI 14th Annual Thought Leaders Consortium

    Loews Coronado Bay Resort 4000 Coronado Bay Rd, Coronado, CA, United States

    The 14th Annual Thought Leaders Consortium marks the culminating chapter of PLMI’s three-year exploration into the biology of immuno-metabolism, epigenetic regulation, and human longevity. Building on the 2024 and 2025 Consortia—which reframed chronic disease through immune-metabolic dysfunction and diet- and environment-driven epigenetic remodeling—this year’s gathering places mitochondria at the center of health, disease, and aging. Once viewed simply as the cell’s energy producers, mitochondria are now recognized as dynamic, epigenetically responsive organelles that integrate nutrition, environmental exposures, immune activation, stress signaling, physical activity, and circadian inputs into a unified metabolic-immune system. Disruption of mitochondrial function is increasingly implicated in fatigue syndromes, chronic pain, immune dysregulation, neurodegeneration, infertility, metabolic disease, accelerated aging, and diminished stress resilience. This advanced, science-driven Consortium convenes world-leading experts to explore mitochondrial biology as the cornerstone of immuno-metabolic resilience. Attendees will gain cutting-edge insights into mitochondrial signaling, mito-nuclear communication, and metabolic flexibility—alongside clinically actionable frameworks for restoring cellular vitality, reversing biological aging trajectories, and extending healthspan. Through deep scientific exploration and translational clinical strategy, the 2026 Thought Leaders Consortium will equip practitioners and researchers with the knowledge needed to redefine assessment, intervention, and long-term outcomes in personalized and lifestyle medicine.

    $650
  • Practical Clinical Skills in Neurotransmitter Optimization: Clinical Herbalism for Mood, Cognition & Aging

    Virtual Event

    Join us for the second part of this two-part virtual symposium! Mental health and neurocognitive disorders remain among the most prevalent and inadequately addressed challenges in modern clinical practice.  This intensive, expert-led symposium provides a comprehensive, clinically grounded framework for integrating herbal and nutraceutical strategies into mental health care. Attendees gain a working understanding of how targeted herbal interventions modulate key neurotransmitter systems, including serotonin, dopamine, GABA, and cortisol, and how to apply these therapies strategically, whether as adjuncts to pharmaceuticals or as standalone options. Clinical applications span a wide spectrum, from anxiety and depression to Parkinson’s-related motor symptoms and age-associated cognitive decline, with a strong emphasis on practical implementation and patient-specific protocol design.

Related Posts

When Screens Replace Connection: Impact on Children’s Brains

By Erik Peper, PhD, BCB, Stoyan Vezenkov, PhD, Violeta Manolovab, Lauren Mason, PhD and Richard Harvey, PhD – The empirical record on educational technology in early and primary education has not delivered on its promises—math and reading scores have declined while screen use in classrooms has risen, as the US NAEP data and Sweden’s recent reversal of its “digital-first” education policy make plain.

Read More

0 Comments

Submit a Comment

Pin It on Pinterest

Share This